New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
Enlicitide achieved all primary and key secondary endpoints, demonstrating statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Facility designed to advance the next generation of imaging systems
Saroglitazar was generally well tolerated, with overall adverse events generally balanced between Saroglitazar-treated and placebo-treated patients
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
Guidelines aim to establish state-regulated veterinary blood banks
The company is bringing precision therapies for gynaecological cancers
Subscribe To Our Newsletter & Stay Updated
